SIX1 transcriptionally activates VEGF-C [65], and overexpression of SIX1 in tumor cells may abrogate the inhibitory effect of TGF-β on lymphangiogenesis by upregulating VEGF-C [66]. The gene discussed is VEGFC; the disease is neoplasm.